Gilad Oren insider trades
Gilad Oren has filed 12 Form 4s with the SEC that we hold, all for Aprea Therapeutics, Inc. (APRE), as President/CEO, Director. Across all of them we count 8 purchases worth $55.4K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($25.0K) and 0 sales ($0). The largest single trade was a purchase of 28,100 shares of Aprea Therapeutics, Inc. worth $25.0K, dated 2026-01-30. The first filing on our record is dated 2022-08-01 and the latest 2026-03-16.
Aprea Therapeutics, Inc. (APRE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-13 | P, purchase reported on Form 4 | 2,000 | $14.6K | 2024-03-14 |
| 2024-10-10 | P, purchase reported on Form 4 | 150 | $381 | 2024-10-15 |
| 2024-10-14 | P, purchase reported on Form 4 | 1,000 | $2.6K | 2024-10-15 |
| 2024-10-15 | P, purchase reported on Form 4 | 250 | $725 | 2024-10-16 |
| 2024-10-23 | P, purchase reported on Form 4 | 500 | $2.0K | 2024-10-24 |
| 2025-04-03 | P, purchase reported on Form 4 | 2,497 | $4.5K | 2025-04-04 |
| 2025-04-03 | P, purchase reported on Form 4 | 3,003 | $5.6K | 2025-04-04 |
| 2026-01-30 | P, purchase reported on Form 4 | 28,100 | $25.0K | 2026-02-02 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1929300) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms